Analyst Research

Report Title Price
Provider: Stock Traders Daily
$58.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Mylan Inc Drops Out Of Rottapharm Talks; Rovati Family Looking To Forest Laboratories, Inc. And Watson Pharmaceuticals, Inc. For Stake Sale-Reuters


Thursday, 15 Mar 2012 02:21pm EDT 

Reuters reported that Mylan Inc has pulled out of talks to buy a stake in Italian pharmaceuticals firm Rottapharm. The Rovati family had been looking to find an investor among pharma groups such as Mylan, Forest Laboratories, Inc. and Watson Pharmaceuticals, Inc., after it failed to sell a minority stake to private equity houses. But the sources said the selling family has not been able to agree to give up control of the company and was not prepared to compromise enough on price either. 

Company Quote

38.53
-0.17 -0.44%
17 May 2013